Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma (Q36639818)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 1998

Language	Label	Description	Also known as
English	Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma	scientific article published on October 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

based on heuristic

inferred from title

metastatic melanoma

1 reference

based on heuristic

inferred from title

Colony stimulating factor 2

1 reference

based on heuristic

inferred from title

author name string

R Soiffer

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

T Lynch

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

M Mihm

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

K Jung

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

C Rhuda

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J C Schmollinger

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

F S Hodi

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

L Liebster

8

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

P Lam

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

S Mentzer

10

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

S Singer

11

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

K K Tanabe

12

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A B Cosimi

13

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

R Duda

14

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A Sober

15

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A Bhan

16

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J Daley

17

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

D Neuberg

18

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

G Parry

19

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J Rokovich

20

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

L Richards

21

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J Drayer

22

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A Berns

23

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

S Clift

24

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

L K Cohen

25

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

R C Mulligan

26

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

G Dranoff

27

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 October 1998

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

95

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

22

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

13141-13146

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Direct evidence to support the immunosurveillance concept in a human regressive melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Activation markers on T cells infiltrating melanoma metastases after therapy with dinitrophenyl-conjugated vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Gene transfer as cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

The histogenesis and biologic behavior of primary human malignant melanomas of the skin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

The eosinophilic leukocyte: structure and function

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

https://api.crossref.org/works/10.1073%2FPNAS.95.22.13141

21 January 2018

Stage II malignant melanoma: presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Model predicting survival in stage I melanoma based on tumor progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Cytokines: coordinators of immune and inflammatory responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Long-term spontaneous regression of malignant melanoma with visceral metastasesReport of a case with immunologic profile

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

28 June 2018

Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

28 June 2018

Active-specific immunotherapy for melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

28 June 2018

Immunization with haptenized, autologous tumor cells induces inflammation of human melanoma metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

28 June 2018

A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

20 September 2018

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

20 September 2018

Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma. Treatment of stage II melanoma with viral lysates

1 reference

https://pubmed.ncbi.nlm.nih.gov/9789055

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/9789055

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of tumor-infiltrating lymphocytes in human malignant melanoma metastases by immunization to melanoma antigen vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/9789055

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous melanoma vaccine induces inflammatory responses in melanoma metastases: relevance to immunologic regression and immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9789055

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside

1 reference

https://pubmed.ncbi.nlm.nih.gov/9789055

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of cytokine mRNA in human melanoma tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/9789055

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

1 reference

https://pubmed.ncbi.nlm.nih.gov/9789055

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response

1 reference

https://pubmed.ncbi.nlm.nih.gov/9789055

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/9789055

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous hapten-modified melanoma vaccine as postsurgical adjuvant treatment after resection of nodal metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/9789055

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.95.22.13141

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1998PNAS...9513141S

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36639818&oldid=2148660773"